Cytovance Biologics, a full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, has promoted Matt Hamilton to vice president, finance. Mr. Hamilton will be leading the finance and accounting function. He has been acting vice president of finance for the past ten months and was director of FP&A prior to being promoted. 
 
“With over 18 years’ experience in finance, Matt brings great depth of experience in finance,” said Joyce Johnson, vice president, human resources. “We are very fortunate and excited to promote Matt into this role and have him on our experienced executive team. Matt’s knowledge and leadership skills continue to be a tremendous asset.”
 
Prior to Cytovance, Mr. Hamilton served as corporate controller for Serva Group, where he oversaw the accounting and finance functions for multiple manufacturing plants. Prior to joining Serva Group, he held the position of plant controller for Johnson Controls, for their unitary products group.